Loratadine Tablet, Orally Disintegrating
Product Images NDC 59556-917

1 FDA label image from Strides Pharma Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Loratadine (NDC 59556-917). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (75feb5a0 Dffb 46af B735 250dd151eb77 01)

Image (75feb5a0 Dffb 46af B735 250dd151eb77 01)
Loratadine Orally Disintegrating Tablets USP, 10 mg packaging label by Strides Pharma Inc. The label indicates it is a non-drowsy antihistamine for indoor and outdoor allergies. The package contains 10 tablets (1 blister of 10) designed to melt in the mouth without water, providing 24-hour relief for symptoms like sneezing, runny nose, itchy watery eyes, and itchy throat or nose. The NDC number 59556-917 is shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.